XML 56 R43.htm IDEA: XBRL DOCUMENT v3.24.3
Equity Incentive Program (Tables)
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Assumptions Used in Determining the Fair Value
The assumptions used in determining the fair value of the SARs awarded during the respective periods were as follows:
SARs
 20242023
Risk-free interest rate4.13 %3.91 %
Dividend yield1.28 %1.32 %
Expected life (years)5.55.4
Volatility31.32 %30.65 %
Grant price
$160.11$153.25
Fair value per share at date of grant
$51.17$47.27
The assumptions used in the Monte Carlo model to determine the fair value of the PSAs granted in the respective periods were as follows:
PSAs
20242023
Risk-free interest rate4.37 %4.28 %
Dividend yield1.15 %1.32 %
Expected life (years)2.82.9
Volatility23.30 %27.30 %
Grant price$177.19$153.25
Fair value per share at date of grant$287.62$249.48
Schedule of Stock-based Incentive Plans Compensation Expense The following table summarizes the Company’s compensation expense relating to all stock-based incentive plans:
 Three Months Ended September 30,Nine Months Ended September 30,
 2024202320242023
Pre-tax stock-based compensation expense$8,187 $6,687 $32,297 $24,836 
Tax benefit(729)(692)(3,141)(2,536)
Total stock-based compensation expense, net of tax$7,458 $5,995 $29,156 $22,300